Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
3-(4-amino-2-tert-butyl-5-methyl-phenylsulfanyl)-6-cyclopentyl-4-hydroxy-6-[2-(4-hydroxy-phenyl)-ethyl]-5,6-dihydro-pyran-2-one
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule with the formula C29H37NO4S and a molecular weight of approximately 495.7 g/mol. It is listed in chemical and pharmaceutical databases as an experimental or research compound but has no approved medical indications or clinical trial activity reported to date. The structure features a pyranone core substituted with phenolic and cyclopentane groups as well as tert-butyl and methyl substituents on the aromatic ring. It has been identified in ZINC15 as a pharmaceutical candidate and flagged by PARC T4.2 as a potential endocrine-disrupting compound[1][2]. No mechanism of action or therapeutic use is established.
- Other names
- (6S)-3-(4-amino-2-tert-butyl-5-methylphenyl)sulfanyl)-6-cyclopentyl-4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-5,6-dihydro-2H-pyran-2-one(6S)-3-(4-amino–2-tert-butyl–5-methylphenyl)sulfanyl–6-cyclopentyl–4-hydroxy–6-[2-(4-hydroxyphenyl)ethyl]–5,6-dihydro–2H-pyran–2-one3-(4-AMINO‑2‑TERT-BUTYL‑5-METHYL-PHENYLSULFANYL)‑6-CYCLOPENTYL‑4-HYDROXY‑6-[2-(4-HYDROXY-PHENYL)-ETHYL]‑5,6-DIHYDRO-PYRAN‑2-One
Beyond the preview
Go deeper on 3-(4-amino-2-tert-butyl-5-methyl-phenylsulfanyl)-6-cyclopentyl-4-hydroxy-6-[2-(4-hydroxy-phenyl)-ethyl]-5,6-dihydro-pyran-2-one.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 3-(4-amino-2-tert-butyl-5-methyl-phenylsulfanyl)-6-cyclopentyl-4-hydroxy-6-[2-(4-hydroxy-phenyl)-ethyl]-5,6-dihydro-pyran-2-one.